Publication | Closed Access
Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?
14
Citations
0
References
2002
Year
HepatologyViral HepatitisLamivudine TherapyPharmacologyAntiviral TherapyHepatitisYmdd MutantsChronic Hepatitis BPharmacotherapyMedicine
No additional data available for this publication yet. Check back later!